| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) | 
|---|
| 03/16/2011 | CN101362796B B cell epitope of epididymal protease inhibitor and multiple antigenic peptide containing thereof | 
| 03/15/2011 | US7906484 Complex for transferring an anionic substance into a cell | 
| 03/15/2011 | US7906482 Peptide YY (PYY) coupled to a group capable of reacting on a blood component so as to form a stable covalent bond, preventing said PYY peptide from crossing the blood brain barrier; improved bioavailability; reduce tumor necrosis factor (TNF)-induced acute pancreatitis | 
| 03/15/2011 | US7906277 Compound and methods for diagnosis of tuberculosis | 
| 03/15/2011 | US7906150 Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium | 
| 03/15/2011 | CA2529062C Antimicrobial polypeptides | 
| 03/15/2011 | CA2470423C Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol | 
| 03/10/2011 | WO2011028507A2 Compositions, methods, and kits for determining an alkyl transferase | 
| 03/10/2011 | WO2011027916A1 Therapeutic agent for allergic diseases | 
| 03/10/2011 | WO2011027868A1 Method for producing 11-sugar sialyloligosaccharide-peptide | 
| 03/10/2011 | WO2011027048A1 Transglutaminase-activating peptide, and cosmetic or pharmaceutical composition containing same | 
| 03/10/2011 | WO2010108164A3 Novel anti-parasitic compounds | 
| 03/10/2011 | WO2010079511A4 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof | 
| 03/10/2011 | US20110060124 Hla-binding peptides, precursors thereof, dna fragments and recombinant vectors that code for those peptide sequences | 
| 03/10/2011 | US20110059889 PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn | 
| 03/10/2011 | US20110059888 Metastin derivatives and use thereof | 
| 03/10/2011 | US20110059501 Protein Glycosylation | 
| 03/10/2011 | US20110059472 Reagents and methods for detecting influenza virus proteins | 
| 03/10/2011 | US20110059092 Antibodies specific of the beta-amyloid peptides and their uses as diagnostic agents or drugs | 
| 03/10/2011 | US20110059091 Inhibitors of oncogenic isoforms and uses thereof | 
| 03/10/2011 | US20110059015 Vaccine | 
| 03/09/2011 | EP2292662A2 Assay and reagents for quantifying hBNP | 
| 03/09/2011 | EP2292655A1 Peptides and related molecules that bind to tall-1 | 
| 03/09/2011 | EP2292642A1 Immunomodulating compositions, uses therefor and processes for their production | 
| 03/09/2011 | EP2292641A2 Expression in filamentous fungi of protease inhibitors and variants thereof | 
| 03/09/2011 | EP2292248A2 Anti-angiogenic compounds | 
| 03/09/2011 | EP2292247A2 Immunizing composition and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein | 
| 03/09/2011 | EP2291391A1 Use of a tpb salt for the separation of biomolecules | 
| 03/09/2011 | EP2291075A2 Gastrin releasing peptide compounds | 
| 03/09/2011 | EP1355910B1 Formulation of boronic acid compounds | 
| 03/09/2011 | CN101068560B Method of screening toxin-neutralizing peptide, STX2 inhibitory peptide and Vero toxin-neutralizing agent | 
| 03/08/2011 | US7902488 Microwave-assisted peptide synthesis | 
| 03/08/2011 | US7902344 Nucleotide sequences coding antibody specific for bacillus anthracis antigen for use in diagnosis, prevention and treatment of anthrax exposure; immunotherapy | 
| 03/08/2011 | US7902331 Forisomes, method for their isolation, and their use as a molecular working machine | 
| 03/08/2011 | US7902330 Protein kinase inhibitors and methods for identifying same | 
| 03/08/2011 | US7902329 Oligopeptide tyrosinase inhibitors and uses thereof | 
| 03/08/2011 | US7902144 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same | 
| 03/08/2011 | US7902143 Cancer antigen peptide and the use thereof | 
| 03/08/2011 | US7901902 Methods and compositions for identifying a cellular immune response against prostate cancer | 
| 03/08/2011 | US7901894 Kinase inhibitors | 
| 03/03/2011 | WO2011026015A2 Stabilized melanocortin ligands | 
| 03/03/2011 | WO2011024482A1 Method for measurement of ability of inducing antigen-specific t cells | 
| 03/03/2011 | WO2011024428A1 Breast cancer related gene c12orf32 | 
| 03/03/2011 | WO2010133806A3 Marked peptides and use thereof for assaying circulating irap | 
| 03/03/2011 | WO2010121023A3 Peptides and aptamers for targeting of neuron or nerves | 
| 03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof | 
| 03/03/2011 | US20110055940 Therapeutic Inhibitors of PAI-1 Function Methods of Their Use | 
| 03/03/2011 | US20110053864 Compositions and methods for modulation of cell migration | 
| 03/03/2011 | US20110053856 Metabolite derivatives of the hdac inhibitor fk228 | 
| 03/03/2011 | US20110053849 Regulation of litaf modulated cytokine production by a novel p53 short peptide | 
| 03/03/2011 | US20110053846 The use of gnrh antagonist peptide in the treatement of sex hormone-dependent diseases | 
| 03/03/2011 | US20110053840 Allele and isotope-specific intervention on mhc class ii molecules associated with autoimmune diseases by means of peptides | 
| 03/03/2011 | US20110053837 Mineral-peptide chelates | 
| 03/03/2011 | US20110053834 Novel antibiotic peptide derived from ribosomal protein l1 of helicobacter pylori and use thereof | 
| 03/03/2011 | US20110053833 Synthetic peptides and their use | 
| 03/03/2011 | US20110053829 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids | 
| 03/03/2011 | US20110053268 Method for diagnosis of abnormal iron metabolism using active hepcidin as indicator | 
| 03/03/2011 | US20110053225 Multifunctional tags | 
| 03/03/2011 | US20110053182 Diagnosis of pre-cancerous conditions using pcdgf agents | 
| 03/03/2011 | US20110053177 Mass spectrometric methods and products | 
| 03/03/2011 | US20110052692 Novel hydrogels and uses thereof | 
| 03/03/2011 | US20110052658 Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration | 
| 03/03/2011 | US20110052615 Tumour-specific animal proteins | 
| 03/03/2011 | US20110052614 Stat3 epitope peptides | 
| 03/03/2011 | US20110052593 Breast cancer associated antigen | 
| 03/03/2011 | US20110052587 Peptide or protein comprising a c'-d loop of the cd28 receptor family | 
| 03/03/2011 | US20110052508 Peptide-based oral care surface reagents for personal care | 
| 03/03/2011 | US20110052491 Gastrin releasing peptide compounds | 
| 03/03/2011 | CA2809803A1 Stabilized melanocortin ligands | 
| 03/03/2011 | CA2772551A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer | 
| 03/03/2011 | CA2772310A1 N-terminal dimerization methods with bis-amindino acid-and bis-thioimidate derivatives | 
| 03/02/2011 | EP2290077A2 Natural IGM antibodies and inhibitors thereof | 
| 03/02/2011 | EP2290055A2 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic and therapeutic applications | 
| 03/02/2011 | EP2289905A1 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2alpha receptor | 
| 03/02/2011 | EP2289564A2 Derivatives of aniline as precursors for F18-labeling | 
| 03/02/2011 | EP2288621A2 Il-23 receptor antagonists and uses thereof | 
| 03/02/2011 | EP2288616A1 Peptidylarginine deiminase (pad) inhibitors | 
| 03/02/2011 | EP2288615A1 Selective caspase inhibitors and uses thereof | 
| 03/02/2011 | EP1934258B1 Antibodies against april as biomarkers for early prognosis of lymphoma patients | 
| 03/02/2011 | EP1844070B1 Peptides with neuropeptide-2 receptor (y2r) agonist activity | 
| 03/02/2011 | EP1673633B9 Method for detecting feline immunodeficiency virus | 
| 03/02/2011 | EP1587907B1 Kunitz domain library | 
| 03/02/2011 | EP1497452B1 Methods for measuring enzyme activity | 
| 03/02/2011 | EP1351992B1 Hybrid peptides for treatment of bacteremia and septicemia | 
| 03/02/2011 | CN1954068B HLA-binding peptide, precursor thereof, DNA fragment encoding the same and recombinant vector | 
| 03/02/2011 | CN101983205A Oxitocin analogues | 
| 03/01/2011 | US7897721 Cyclic peptide compositions for treatment of sexual dysfunction | 
| 02/24/2011 | WO2011021581A1 Selective marker for target biopolymer | 
| 02/24/2011 | WO2011021524A1 Peptides inducing adhesive property of lactic acid bacterium and use of same | 
| 02/24/2011 | WO2011020596A2 Cyclosporine derivates | 
| 02/24/2011 | WO2011020188A1 Peptide sequences and peptide-mediated sirna delivery | 
| 02/24/2011 | WO2011020133A1 Use of mimotopes of alpha-synuclein epitopes for treating lewy body diseases | 
| 02/24/2011 | US20110046070 Gene expression inhibitor selective for matrix metalloproteinase-9 gene | 
| 02/24/2011 | US20110046068 Compound, Use and Method | 
| 02/24/2011 | US20110046043 Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices | 
| 02/24/2011 | US20110046042 Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof | 
| 02/24/2011 | US20110046020 Novel ion channel-forming peptides | 
| 02/24/2011 | US20110045605 Characterization of Granulocytic Ehrlichia and Methods of Use | 
| 02/24/2011 | US20110045604 Molecular affinity clamp technology and uses thereof | 
| 02/24/2011 | US20110045538 Peptide, Use Of The Peptide, Method For The Production Of The Peptide, Solid Support Having The Peptide Immobilized Thereon, And Method For Production Of The Solid Support |